346 related articles for article (PubMed ID: 31587392)
1. Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings.
Duan T; Verkman AS
Brain Pathol; 2020 Jan; 30(1):13-25. PubMed ID: 31587392
[TBL] [Abstract][Full Text] [Related]
2. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
3. Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.
Yao X; Verkman AS
Acta Neuropathol Commun; 2017 Jul; 5(1):57. PubMed ID: 28750658
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica pathogenesis and aquaporin 4.
Graber DJ; Levy M; Kerr D; Wade WF
J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
Zhang H; Bennett JL; Verkman AS
Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
[TBL] [Abstract][Full Text] [Related]
7. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
Yao X; Verkman AS
Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
[TBL] [Abstract][Full Text] [Related]
8. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
9. CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica.
Tradtrantip L; Duan T; Yeaman MR; Verkman AS
J Neuroinflammation; 2019 Mar; 16(1):57. PubMed ID: 30851734
[TBL] [Abstract][Full Text] [Related]
10. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.
Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH
J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018
[TBL] [Abstract][Full Text] [Related]
11. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
Tradtrantip L; Felix CM; Spirig R; Morelli AB; Verkman AS
Neuropharmacology; 2018 May; 133():345-353. PubMed ID: 29428821
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
13. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.
Ratelade J; Bennett JL; Verkman AS
J Biol Chem; 2011 Dec; 286(52):45156-64. PubMed ID: 22069320
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.
Ratelade J; Verkman AS
Int J Biochem Cell Biol; 2012 Sep; 44(9):1519-30. PubMed ID: 22713791
[TBL] [Abstract][Full Text] [Related]
15. Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.
Matiello M; Schaefer-Klein J; Sun D; Weinshenker BG
JAMA Neurol; 2013 Sep; 70(9):1118-25. PubMed ID: 23857303
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System.
Abe Y; Yasui M
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454180
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.
Grünewald B; Bennett JL; Toyka KV; Sommer C; Geis C
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571069
[TBL] [Abstract][Full Text] [Related]
18. Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.
Asavapanumas N; Ratelade J; Papadopoulos MC; Bennett JL; Levin MH; Verkman AS
J Neuroinflammation; 2014 Jan; 11():16. PubMed ID: 24468108
[TBL] [Abstract][Full Text] [Related]
19. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
20. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]